Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of NICE - Depositary Receipt () (NasdaqGS:NICE) ...

Fintel reports that on January 17, 2025, Cantor Fitzgerald downgraded their outlook for Polestar Automotive Holding UK PLC - ...

Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Rigel Pharmaceuticals in a ...

New U.S. Secretary of Commerce Howard Lutnick plans to continue the CHIPS Act initiated by the Biden Administration. Read ...

In a report released today, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Prenetics Group (PRE – Research Report), with a price ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research Report) on January 14 and set a price ...

H.C. Wainwright has recently initiated Verve Therapeutics Inc (VERV) stock to Buy rating, as announced on April 8, 2024, according to Finviz. Earlier, on April 13, 2023, Canaccord Genuity had ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

LIGHT (NASDAQ:LASR – Free Report) had its target price trimmed by Stifel Nicolaus from $17.00 to $14.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage ...

In a recent blog post, OpenAI CEO Sam Altman said that as OpenAI continues to advance it has moved beyond research to product ...

Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share. The shares began ...